Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol

BACKGROUND: Atopic dermatitis (AD) is a common eczematous skin disorder that profoundly reduces the quality of life due to intractable pruritus. Excellent therapeutic success of the anti-interleukin 4 receptor-α antibody dupilumab in clinical trials and a real-world clinical context indicates the cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakahara, Takeshi, Izuhara, Kenji, Onozuka, Daisuke, Nunomura, Satoshi, Tamagawa-Mineoka, Risa, Masuda, Koji, Ichiyama, Susumu, Saeki, Hidehisa, Kabata, Yudai, Abe, Riichiro, Ohtsuki, Mamitaro, Kamiya, Koji, Okano, Tatsuro, Miyagaki, Tomomitsu, Ishiuji, Yozo, Asahina, Akihiko, Kawasaki, Hiroshi, Tanese, Keiji, Mitsui, Hiroshi, Kawamura, Tatsuyoshi, Takeichi, Takuya, Akiyama, Masashi, Nishida, Emi, Morita, Akimichi, Tonomura, Kyoko, Nakagawa, Yukinobu, Sugawara, Koji, Tateishi, Chiharu, Kataoka, Yoko, Fujimoto, Rai, Kaneko, Sakae, Morita, Eishin, Tanaka, Akio, Hide, Michihiro, Aoki, Natsuko, Sano, Shigetoshi, Matsuda-Hirose, Haruna, Hatano, Yutaka, Takenaka, Motoi, Murota, Hiroyuki, Katoh, Norito, Furue, Masutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505282/
https://www.ncbi.nlm.nih.gov/pubmed/32957324
http://dx.doi.org/10.1097/MD.0000000000022043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505282/
https://www.ncbi.nlm.nih.gov/pubmed/32957324
http://dx.doi.org/10.1097/MD.0000000000022043

Ejemplares similares